Cargando…

A Generic Model for Follicular Lymphoma: Predicting Cost, Life Expectancy, and Quality-Adjusted-Life-Year Using UK Population–Based Observational Data()

OBJECTIVES: To use real-world data to develop a flexible generic decision model to predict cost, life expectancy, and quality-adjusted life-years (QALYs) for follicular lymphoma (FL) in the general patient population. METHODS: All patients newly diagnosed with FL in the UK’s population-based Haemato...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Han-I, Roman, Eve, Crouch, Simon, Aas, Eline, Burton, Cathy, Patmore, Russell, Smith, Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191529/ https://www.ncbi.nlm.nih.gov/pubmed/30314618 http://dx.doi.org/10.1016/j.jval.2018.03.007

Ejemplares similares

Treatment cost and life expectancy of diffuse large B-cell lymphoma (DLBCL): a discrete event simulation model on a UK population-based observational cohort
por: Wang, Han-I., et al.
Publicado: (2016)

Impact of age and socioeconomic status on treatment and survival from aggressive lymphoma: a UK population-based study of diffuse large B-cell lymphoma
por: Smith, Alexandra, et al.
Publicado: (2015)

Emergency admission and survival from aggressive non-Hodgkin lymphoma: A report from the UK's population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2017)

Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)
por: Smith, Alexandra, et al.
Publicado: (2018)

The impact of rheumatological disorders on lymphomas and myeloma: a report on risk and survival from the UK’s population-based Haematological Malignancy Research Network
por: Kane, Eleanor, et al.
Publicado: (2019)

Molecular subclusters of follicular lymphoma: a report from the United Kingdom’s Haematological Malignancy Research Network
por: Crouch, Simon, et al.
Publicado: (2022)

Cohort Profile: The Haematological Malignancy Research Network (HMRN): a UK population-based patient cohort
por: Smith, Alexandra, et al.
Publicado: (2018)

Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada
por: Loukine, Lidia, et al.
Publicado: (2012)

Hodgkin lymphoma detection and survival: findings from the Haematological Malignancy Research Network
por: Lamb, Maxine JE, et al.
Publicado: (2019)

Myeloid malignancies in the real-world: Occurrence, progression and survival in the UK’s population-based Haematological Malignancy Research Network 2004–15
por: Roman, Eve, et al.
Publicado: (2016)

Cohort Profile Update: The Haematological Malignancy Research Network (HMRN) UK population-based cohorts
por: Roman, Eve, et al.
Publicado: (2022)

‘Unpacking’ pathways to lymphoma and myeloma diagnosis: Do experiences align with the Model of Pathways to Treatment? Findings from a UK qualitative study with patients and relatives
por: Howell, Debra, et al.
Publicado: (2020)

Impact of overweight and obesity on life expectancy, quality-adjusted life years and lifetime costs in the adult population of Ghana
por: Lartey, Stella, et al.
Publicado: (2020)

Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network
por: Smith, A, et al.
Publicado: (2015)

Adjusting for dependent comorbidity in the calculation of healthy life expectancy
por: Mathers, Colin D, et al.
Publicado: (2006)

Need for risk adjustment in comparative effectiveness and cost-effectiveness studies in r/r follicular lymphoma
por: Gribben, John, et al.
Publicado: (2023)

Disability weights for comorbidity and their influence on Health-adjusted Life Expectancy
por: van Baal, Pieter HM, et al.
Publicado: (2006)

Health-Adjusted Life Expectancy (HALE) in Korea: 2005–2011
por: Lee, Jin Yong, et al.
Publicado: (2016)

Changes in quality-adjusted life expectancy in Belgium, 2013 and 2018
por: Scohy, Aline, et al.
Publicado: (2022)

Comparing life expectancy and health-adjusted life expectancy by body mass index category in adult Canadians: a descriptive study
por: Steensma, Colin, et al.
Publicado: (2013)

Changes and Trend Disparities in Life Expectancy and Health-Adjusted Life Expectancy Attributed to Disability and Mortality From 1990 to 2019 in China
por: Chen, Lijun, et al.
Publicado: (2022)

Divergences and gaps in life expectancy and health-adjusted life expectancy in Mexico: Contribution analysis of the Global Burden of Disease Study 2019
por: Agudelo-Botero, Marcela, et al.
Publicado: (2023)

Stillbirths: how should its rate be reported, its disability-adjusted-life-years (DALY), and stillbirths adjusted life expectancy
por: Kant, Chander
Publicado: (2019)

Updating Disability Weights for Measurement of Healthy Life Expectancy and Disability-adjusted Life Year in Korea
por: Kim, Young-Eun, et al.
Publicado: (2020)

Decomposition of Quality-Adjusted Life Expectancy Inequalities by Mortality and Health-Related Quality of Life Dimensions
por: Love-Koh, James, et al.
Publicado: (2023)

Health-Adjusted Life Expectancy among Canadian Adults with and without Hypertension
por: Loukine, Lidia, et al.
Publicado: (2011)

The gaps in health-adjusted life Expectancy (HALE) by income and region in Korea
por: Jung, YS, et al.
Publicado: (2022)

The Trends in Health Life Expectancy in Korea according to Age, Gender, Education Level, and Subregion: Using Quality-Adjusted Life Expectancy Method
por: Jo, Min-Woo, et al.
Publicado: (2018)

Incurable but treatable: Understanding, uncertainty and impact in chronic blood cancers—A qualitative study from the UK’s Haematological Malignancy Research Network
por: Howell, Debra A., et al.
Publicado: (2022)

Care pathways at end-of-life for cancer decedents: registry based analyses of the living situation, healthcare utilization and costs for all cancer decedents in Norway in 2009-2013 during their last 6 months of life
por: Bjørnelv, Gudrun, et al.
Publicado: (2022)

Cost-Effectiveness Analyses, Costs and Resource Use, and Health-Related Quality of Life in Patients with Follicular or Marginal Zone Lymphoma: Systematic Reviews
por: Monga, Neerav, et al.
Publicado: (2020)

Hodgkin's lymphoma and infection: findings from a UK case–control study
por: Newton, R, et al.
Publicado: (2007)

Inequality in quality-adjusted life expectancy by educational attainment in Norway: an observational study
por: Gutacker, Nils, et al.
Publicado: (2023)

Total knee arthroplasty improves the quality-adjusted life years in patients who exceeded their estimated life expectancy
por: Palazzuolo, Michele, et al.
Publicado: (2021)

Multiple myeloma: routes to diagnosis, clinical characteristics and survival – findings from a UK population‐based study
por: Howell, Debra, et al.
Publicado: (2017)

Disease-related factors affecting timely lymphoma diagnosis: a qualitative study exploring patient experiences
por: Howell, Debra A, et al.
Publicado: (2019)

Measurement properties of the UK-English version of the Pediatric Quality of Life Inventory™ 4.0 (PedsQL™) generic core scales
por: Upton, Penney, et al.
Publicado: (2005)

Estimating health-adjusted life expectancy conditional on risk factors: results for smoking and obesity
por: van Baal, Pieter HM, et al.
Publicado: (2006)

Decomposing cross-country differences in quality adjusted life expectancy: the impact of value sets
por: Heijink, Richard, et al.
Publicado: (2011)

Income-related inequality in quality-adjusted life expectancy in Korea at the national and district levels
por: Lim, Dohee, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d0e07akv6qcduhnpa7apao41ad